Work

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

Year: 2018

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Infectious Diseases

DOI: 10.1016/s1473-3099(18)30554-1

Authors: Simon Portsmouth, David van Veenhuyzen, Roger Echols, Mitsuaki Machida, Juan Camilo Arjona Ferreira, Mari Ariyasu, Peter Tenke, Tsutae Den Nagata

Institutions: Shionogi (United States), Shionogi (Japan), Jahn Ferenc Dél-Pesti Kórház és Rendelőintézet

Language: English

Topic: Urinary Tract Infections Management

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cell Science Research Foundation, Shionogi

OpenAlex ID: W2898144230

FWCI: 46.52

Cites: 23

Cited by: 431

Related to: 10